93 7471 (Rizatriptan benzoate 5 mg (base))
Pill imprint 93 7471 has been identified as Rizatriptan benzoate 5 mg (base).
Rizatriptan is used in the treatment of migraine and belongs to the drug class antimigraine agents. Risk cannot be ruled out during pregnancy. Rizatriptan 5 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).
- 93 7471
- 5 mg (base)
- Prescription only
- Drug Class:
- Antimigraine agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Teva Pharmaceuticals USA Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose monohydrate
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.
More about rizatriptan
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 195 Reviews – Add your own review/rating
- Drug class: antimigraine agents
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.